TY - JOUR AU - Dearnaley, D. P. AU - Jovic, G. AU - Syndikus, I. AU - Khoo, V. AU - Cowan, R. A. AU - Graham, J. D. AU - Aird, E. G. AU - Bottomley, D. AU - Huddart, R. A. AU - Jose, C. C. PY - 2014 DA - 2014// TI - Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70040-3 DO - 10.1016/S1470-2045(14)70040-3 ID - Dearnaley2014 ER - TY - JOUR AU - Storey, M. R. AU - Pollack, A. AU - Zagars, G. AU - Smith, L. AU - Antolak, J. AU - Rosen, I. PY - 2000 DA - 2000// TI - Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial JO - Int J Radiat Oncol Biol Phys VL - 48 UR - https://doi.org/10.1016/S0360-3016(00)00700-8 DO - 10.1016/S0360-3016(00)00700-8 ID - Storey2000 ER - TY - JOUR AU - Brenner, D. J. AU - Martinez, A. A. AU - Edmundson, G. K. AU - Mitchell, C. AU - Thames, H. D. AU - Armour, E. P. PY - 2002 DA - 2002// TI - Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue JO - Int J Radiat Oncol Biol Phys VL - 52 UR - https://doi.org/10.1016/S0360-3016(01)02664-5 DO - 10.1016/S0360-3016(01)02664-5 ID - Brenner2002 ER - TY - JOUR AU - Brenner, D. J. AU - Hall, E. J. PY - 1999 DA - 1999// TI - Fractionation and protraction for radiotherapy of prostate carcinoma JO - Int J Radiat Oncol Biol Phys VL - 43 UR - https://doi.org/10.1016/S0360-3016(98)00438-6 DO - 10.1016/S0360-3016(98)00438-6 ID - Brenner1999 ER - TY - JOUR AU - Fowler, J. F. PY - 2005 DA - 2005// TI - The radiobiology of prostate cancer including new aspects of fractionated radiotherapy JO - Acta Oncol VL - 44 UR - https://doi.org/10.1080/02841860410002824 DO - 10.1080/02841860410002824 ID - Fowler2005 ER - TY - JOUR AU - Lee, W. R. AU - Dignam, J. J. AU - Amin, M. B. AU - Bruner, D. W. AU - Low, D. AU - Swanson, G. P. AU - Shah, A. B. AU - D'Souza, D. P. AU - Michalski, J. M. AU - Dayes, I. S. PY - 2016 DA - 2016// TI - Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate Cancer JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.0448 DO - 10.1200/JCO.2016.67.0448 ID - Lee2016 ER - TY - JOUR AU - Lukka, H. AU - Hayter, C. AU - Julian, J. A. AU - Warde, P. AU - Morris, W. J. AU - Gospodarowicz, M. AU - Levine, M. AU - Sathya, J. AU - Choo, R. AU - Prichard, H. PY - 2005 DA - 2005// TI - Randomized trial comparing two fractionation schedules for patients with localized prostate cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.153 DO - 10.1200/JCO.2005.06.153 ID - Lukka2005 ER - TY - JOUR AU - Incrocci, L. AU - Wortel, R. C. AU - Alemayehu, W. G. AU - Aluwini, S. AU - Schimmel, E. AU - Krol, S. AU - van der Toorn, P. P. AU - Jager, H. AU - Heemsbergen, W. AU - Heijmen, B. AU - Pos, F. PY - 2016 DA - 2016// TI - Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30070-5 DO - 10.1016/S1470-2045(16)30070-5 ID - Incrocci2016 ER - TY - JOUR AU - Kollar, L. AU - Rengan, R. PY - 2014 DA - 2014// TI - Stereotactic body radiotherapy JO - Semin Oncol VL - 41 UR - https://doi.org/10.1053/j.seminoncol.2014.09.022 DO - 10.1053/j.seminoncol.2014.09.022 ID - Kollar2014 ER - TY - JOUR AU - Timmerman, R. D. AU - Kavanagh, B. D. AU - Cho, L. C. AU - Papiez, L. AU - Xing, L. PY - 2007 DA - 2007// TI - Stereotactic body radiation therapy in multiple organ sites JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.7469 DO - 10.1200/JCO.2006.09.7469 ID - Timmerman2007 ER - TY - JOUR AU - King, C. R. AU - Brooks, J. D. AU - Gill, H. AU - Presti, J. C. PY - 2012 DA - 2012// TI - Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate Cancer JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.11.054 DO - 10.1016/j.ijrobp.2010.11.054 ID - King2012 ER - TY - JOUR AU - Chen, L. N. AU - Suy, S. AU - Uhm, S. AU - Oermann, E. K. AU - Ju, A. W. AU - Chen, V. AU - Hanscom, H. N. AU - Laing, S. AU - Kim, J. S. AU - Lei, S. PY - 2013 DA - 2013// TI - Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience JO - Radiat Oncol VL - 8 UR - https://doi.org/10.1186/1748-717X-8-58 DO - 10.1186/1748-717X-8-58 ID - Chen2013 ER - TY - JOUR AU - Oliai, C. AU - Lanciano, R. AU - Sprandio, B. AU - Yang, J. AU - Lamond, J. AU - Arrigo, S. AU - Good, M. AU - Mooreville, M. AU - Garber, B. AU - Brady, L. W. PY - 2013 DA - 2013// TI - Stereotactic body radiation therapy for the primary treatment of localized prostate cancer JO - J Radiat Oncol VL - 2 UR - https://doi.org/10.1007/s13566-012-0067-2 DO - 10.1007/s13566-012-0067-2 ID - Oliai2013 ER - TY - STD TI - Alongi F, Mazzola R, Fiorentino A, Corradini S, Aiello D, Figlia V, Gregucci F, Ballario R, Cavalleri S, Ruggieri R. Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer. Strahlenther Onkol. 2018. [Epub ahead of print]. ID - ref14 ER - TY - JOUR AU - Zietman, A. L. AU - Tibbs, M. K. AU - Dallow, K. C. AU - Smith, C. T. AU - Althausen, A. F. AU - Zlotecki, R. A. AU - Shipley, W. U. PY - 1996 DA - 1996// TI - Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate JO - Radiother Oncol VL - 40 UR - https://doi.org/10.1016/0167-8140(96)01770-7 DO - 10.1016/0167-8140(96)01770-7 ID - Zietman1996 ER - TY - JOUR AU - Pollack, A. AU - Zagars, G. K. AU - Antolak, J. A. AU - Kuban, D. A. AU - Rosen, I. I. PY - 2002 DA - 2002// TI - Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial JO - Int J Radiat Oncol Biol Phys VL - 54 UR - https://doi.org/10.1016/S0360-3016(02)02977-2 DO - 10.1016/S0360-3016(02)02977-2 ID - Pollack2002 ER - TY - JOUR AU - Shi, Z. AU - Pinnock, C. B. AU - Kinsey-Trotman, S. AU - Borg, M. AU - Moretti, K. L. AU - Walsh, S. AU - Kopsaftis, T. PY - 2013 DA - 2013// TI - Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death JO - Radiother Oncol VL - 107 UR - https://doi.org/10.1016/j.radonc.2013.03.030 DO - 10.1016/j.radonc.2013.03.030 ID - Shi2013 ER - TY - JOUR AU - Ray, M. E. AU - Thames, H. D. AU - Levy, L. B. AU - Horwitz, E. M. AU - Kupelian, P. A. AU - Martinez, A. A. AU - Michalski, J. M. AU - Pisansky, T. M. AU - Shipley, W. U. AU - Zelefsky, M. J. PY - 2006 DA - 2006// TI - PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis JO - Int J Radiat Oncol Biol Phys VL - 64 UR - https://doi.org/10.1016/j.ijrobp.2005.07.006 DO - 10.1016/j.ijrobp.2005.07.006 ID - Ray2006 ER - TY - JOUR AU - Freeman, D. E. AU - King, C. R. PY - 2011 DA - 2011// TI - Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes JO - Radiat Oncol VL - 6 UR - https://doi.org/10.1186/1748-717X-6-3 DO - 10.1186/1748-717X-6-3 ID - Freeman2011 ER - TY - JOUR AU - Katz, A. J. AU - Santoro, M. AU - Diblasio, F. AU - Ashley, R. PY - 2013 DA - 2013// TI - Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years JO - Radiat Oncol VL - 8 UR - https://doi.org/10.1186/1748-717X-8-118 DO - 10.1186/1748-717X-8-118 ID - Katz2013 ER - TY - JOUR AU - Katz, A. AU - Kang, J. PY - 2014 DA - 2014// TI - Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study JO - Radiat Oncol VL - 9 UR - https://doi.org/10.1186/1748-717X-9-1 DO - 10.1186/1748-717X-9-1 ID - Katz2014 ER - TY - JOUR AU - Boike, T. P. AU - Lotan, Y. AU - Cho, L. C. AU - Brindle, J. AU - DeRose, P. AU - Xie, X. J. AU - Yan, J. AU - Foster, R. AU - Pistenmaa, D. AU - Perkins, A. PY - 2011 DA - 2011// TI - Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.4377 DO - 10.1200/JCO.2010.31.4377 ID - Boike2011 ER - TY - JOUR AU - Kotecha, R. AU - Djemil, T. AU - Tendulkar, R. D. AU - Reddy, C. A. AU - Thousand, R. A. AU - Vassil, A. AU - Stovsky, M. AU - Berglund, R. K. AU - Klein, E. A. AU - Stephans, K. L. PY - 2016 DA - 2016// TI - Dose-escalated stereotactic body radiation therapy for patients with intermediate- and high-risk prostate Cancer: initial dosimetry analysis and patient outcomes JO - Int J Radiat Oncol Biol Phys VL - 95 UR - https://doi.org/10.1016/j.ijrobp.2016.02.009 DO - 10.1016/j.ijrobp.2016.02.009 ID - Kotecha2016 ER - TY - JOUR AU - Lee, W. R. AU - Hanlon, A. L. AU - Hanks, G. E. PY - 1996 DA - 1996// TI - Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival JO - J Urol VL - 156 UR - https://doi.org/10.1016/S0022-5347(01)65876-2 DO - 10.1016/S0022-5347(01)65876-2 ID - Lee1996 ER - TY - JOUR AU - Zelefsky, M. J. AU - Shi, W. AU - Yamada, Y. AU - Kollmeier, M. A. AU - Cox, B. AU - Park, J. AU - Seshan, V. E. PY - 2009 DA - 2009// TI - Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality JO - Int J Radiat Oncol Biol Phys VL - 75 UR - https://doi.org/10.1016/j.ijrobp.2008.12.067 DO - 10.1016/j.ijrobp.2008.12.067 ID - Zelefsky2009 ER - TY - JOUR AU - Kishan, A. U. AU - Wang, P. C. AU - Upadhyaya, S. K. AU - Hauswald, H. AU - Demanes, D. J. AU - Nickols, N. G. AU - Kamrava, M. AU - Sadeghi, A. AU - Kupelian, P. A. AU - Steinberg, M. L. PY - 2016 DA - 2016// TI - SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer JO - Pract Radiat Oncol VL - 6 UR - https://doi.org/10.1016/j.prro.2015.11.002 DO - 10.1016/j.prro.2015.11.002 ID - Kishan2016 ER - TY - JOUR AU - Anwar, M. AU - Weinberg, V. AU - Chang, A. J. AU - Hsu, I. C. AU - Roach, M. AU - Gottschalk, A. PY - 2014 DA - 2014// TI - Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir JO - Radiat Oncol VL - 9 UR - https://doi.org/10.1186/1748-717X-9-42 DO - 10.1186/1748-717X-9-42 ID - Anwar2014 ER - TY - JOUR AU - Kole, T. P. AU - Chen, L. N. AU - Obayomi-Davies, O. AU - Kim, J. S. AU - Lei, S. AU - Suy, S. AU - Dritschilo, A. AU - Collins, S. P. PY - 2015 DA - 2015// TI - Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer JO - Acta Oncol VL - 54 UR - https://doi.org/10.3109/0284186X.2014.983656 DO - 10.3109/0284186X.2014.983656 ID - Kole2015 ER - TY - JOUR AU - Aihara, M. AU - Wheeler, T. M. AU - Ohori, M. AU - Scardino, P. T. PY - 1994 DA - 1994// TI - Heterogeneity of prostate cancer inradical prostatectomy specimens JO - Urology VL - 43 UR - https://doi.org/10.1016/S0090-4295(94)80264-5 DO - 10.1016/S0090-4295(94)80264-5 ID - Aihara1994 ER - TY - JOUR AU - Ruijter, E. T. AU - van de Kaa, C. A. AU - Schalken, J. A. AU - Debruyne, F. M. AU - Ruiter, D. J. PY - 1996 DA - 1996// TI - Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications JO - J Pathol VL - 180 UR - https://doi.org/3.0.CO;2-W DO - 3.0.CO;2-W ID - Ruijter1996 ER -